{
    "2021-08-25": [
        [
            {
                "time": "",
                "original_text": "健帆生物：目前公司海外市场收入主要来自东南亚及欧洲国家",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "海外市场",
                        "东南亚",
                        "欧洲"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}